Anti Human Complement C-3 (B1C/B1A) FITC

Anti Human Complement C-3 (B1C/B1A) FITC, Low F/P - 2-4.9 - Direct Tag • Monospecificity by solid phase adsorption for a strong tag with a low background • High antibody titer equals more dilution and dollar value • Choice of F/P ratio; high for indirect tags – low for direct tags • FITC Conjugates • Made in Goat • IN VITRO Diagnostic Use         Antiserum to human C-3  is produced in goats by immunization with purified human C-3.  The gamma globulin fraction of the absorbed, monospecific (B 1C/B1A) antiserum is then prepared, followed by reaction with fluorescein isothiocyanate.  The excess dye is removed by dialysis and the conjugated globulin further fractionated on DEAE cellulose to remove under- and overlabelled protein.  Total protein is determined by the Biuret reaction and the concentration of fluorescein by comparison with a fluorescein diacetate standard.  Sodium azide (0.1% w/v) is added as preservative.